Regarding secondary AML from previous MPN disease, all four cases with ASXL1 mutation lacked NPM1 mutations and were characterized by a coexistence of ASXL1 and TET2, EZH2 and JAK2 mutations. This evidence concerns the gene NPM1 and myeloproliferative neoplasm.